Literature DB >> 6969855

Surface antigen differentiation during human myogenesis in culture.

F S Walsh, M A Ritter.   

Abstract

The fusion of mononucleate myoblast cells into multinucleate myotubes (myogenesis) has often been studied as a model system of terminal cellular differentiation. Although cell-surface changes during myogenesis have attracted much attention and a variety of surface antigens including the nicotinic cholinergic receptor, acetylcholinesterase and muscle lectins have been shown to be present on muscle cells, a detailed identification of markers specific to the various cell types has not been attempted. This is mainly because fibroblasts are a major contaminating cell type in primary muscle cultures and these cells have no known distinctive cell-surface antigen(s). For instance, surface fibronectin has been used to distinguish fibroblasts in the rat peripheral nervous system in vitro but has proved ineffective in the human muscle cell system. In addition, Lesley and Lennon found that Thy-1 antigen was present on myoblasts but not myotubes of the rat L6 muscle cell line and primary cultures. However, Thy-1 antigen is also present on rat fibroblasts. Thus, unequivocal identification of the major mononucleate cell types in muscle cultures, fibroblasts and myoblasts has not been possible. We report here the use of two surface antigens, Thy-1 and a muscle-specific antigen recognized by a monoclonal antibody, to identify unambiguously the four major types of cells present in human muscle cultures and to propose a model of cell-surface differentiation during human myogenesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6969855     DOI: 10.1038/289060a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  33 in total

1.  Isolation and characterization of human fetal myoblasts.

Authors:  Ariya D Lapan; Emanuela Gussoni
Journal:  Methods Mol Biol       Date:  2012

2.  A novel in vitro three-dimensional skeletal muscle model.

Authors:  Michele L Marquette; Diane Byerly; Marguerite Sognier
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-05       Impact factor: 2.416

3.  Isolation, characterization and culture of Thy1-positive cells from fetal rat livers.

Authors:  Zvibel Isabel; Bronstein Miri; Hubel Einav; Bar-Lev Ella; Halpern Zamir; Oren Ran
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Ultrastructural assessment of developmentally regulated cell surface antigens in human muscle cultures by immunogold labelling.

Authors:  R Yasin; D N Landon
Journal:  Histochem J       Date:  1987-03

5.  A rapid preparation of primary cultures of mouse skeletal muscle cells.

Authors:  L Metzinger; P Poindron; A C Passaquin
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  Myocardial localization and isoforms of neural cell adhesion molecule (N-CAM) in the developing and transplanted human heart.

Authors:  L Gordon; J Wharton; S E Moore; F S Walsh; J G Moscoso; R Penketh; J Wallwork; K M Taylor; M H Yacoub; J M Polak
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 7.  Chemical carcinogenesis -- the price for DNA - repair?

Authors:  U Wintersberger
Journal:  Naturwissenschaften       Date:  1982-03

8.  Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene.

Authors:  G Dickson; D R Love; K E Davies; K E Wells; T A Piper; F S Walsh
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

9.  Sodium and potassium currents in freshly isolated and in proliferating human muscle satellite cells.

Authors:  M Hamann; H Widmer; A Baroffio; J P Aubry; R M Krause; A Kaelin; C R Bader
Journal:  J Physiol       Date:  1994-03-01       Impact factor: 5.182

10.  Human muscular fetal cells: a potential cell source for muscular therapies.

Authors:  Nathalie Hirt-Burri; Anthony S de Buys Roessingh; Corinne Scaletta; Stefan Gerber; Dominique P Pioletti; Lee Ann Applegate; Judith Hohlfeld
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.